Elsevier

Biochemical Pharmacology

Volume 33, Issue 23, 1 December 1984, Pages 3847-3852
Biochemical Pharmacology

Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism

https://doi.org/10.1016/0006-2952(84)90050-9Get rights and content

Abstract

Adenosine, at physiological concentrations, may modulate histamine release from mechanically dispersed human lung mast cells. Addition of adenosine to the dispersed mast cells at times up to 5 min before immunological challenge with anti-human IgE inhibited histamine release. When added after this time adenosine caused a small potentiation of immunological histamine release, maximum potentiation occurring with addition of adenosine 5 min after challenge, coincidental with the end of the rapid phase of histamine release. Both inhibition and potentiation of histamine release were more pronounced with low levels of immunological challenge. Theophylline, 8-phenyltheophylline, dipyridamole and analogues of adenosine were used to determine the site of action of adenosine on mast cell mediator release. Theophylline and 8-phenyltheophylline displaced the concentration-response lines for both inhibition and potentiation of mediator release by adenosine to the right whilst dipyridamole, 1 μM, was without significant effect. This suggests that both effects result from interaction of adenosine with cell surface receptors. This was confirmed by demonstrating that the P-site agonist 2',5'-dideoxyadenosine produced only inhibition of histamine release, an effect which was inhibited by dipyridamole but not by theophylline. The rank potency order of adenosine analogues, NECAadenosineL-PIAD in both inhibiting and potentiating immunological histamine release suggests that both effects are mediated through activation of cell surface A2-purinoceptors. Since adenosine is released into the circulation of asthmatic subjects following bronchial provocation with antigen, causes bronchoconstriction and has the ability to modulate mast cell histamine release, this nucleoside should be considered as an additional inflammatory mediator of allergic reactions.

References (32)

  • A.F. Welton et al.

    Biochem. Pharmac.

    (1980)
  • R.F. Bruns

    Biochem. Pharmac.

    (1981)
  • S.G. Griffith et al.

    Eur. J. Pharmac.

    (1981)
  • F.W. Smellie et al.

    Life Sci.

    (1979)
  • R.B. Clark et al.

    J. biol. Chem.

    (1974)
  • P.J. Hughes et al.

    Biochem. Pharmac.

    (1983)
  • M. Huang et al.

    Biochem. Pharmac.

    (1976)
  • D. Van Calker et al.

    J.Neurochem.

    (1979)
  • C. Londos et al.
  • J.W. Daly

    J. med. Chem.

    (1982)
  • J. Wolff et al.

    Adv. Cyc. Nuc. Res.

    (1981)
  • D.L. Marquardt et al.

    J. Immunol.

    (1978)
  • S.T. Holgate et al.
  • G. Marone et al.

    J. Immunol.

    (1979)
  • P.A. Hillyard et al.

    Br. J. Pharmac.

    (1984)
  • Cited by (157)

    • Bronchoprovocation Testing in Asthma: An Update

      2018, Immunology and Allergy Clinics of North America
      Citation Excerpt :

      Adenosine exerts its effects through interaction with specific adenosine (P1) receptors. The exact mechanism of action of AMP on airway wall is not well-defined, but the role of mast cells is crucial based on a variety of inflammatory mediators, such as histamine, prostaglandins, leukotrienes, and IL-8 release, from human mast cells enhanced by adenosine in vitro.156–159 Although there are studies that have shown differential BHR response to antiinflammatories such as ICSs, there are also those that show concordant effects of these medications on bronchial responsiveness to direct and indirect stimuli.143,160–163

    • Adenosine activates Gα<inf>s</inf> proteins and inhibits C3a-induced activation of human mast cells

      2018, Biochemical Pharmacology
      Citation Excerpt :

      Adenosine alone stimulates the production of interleukin (IL)-4 and IL-8 in the human MC line HMC-1, which expresses A2A and A2B receptors [31]. In clear contrast, adenosine inhibits IgE-induced degranulation of human skin MC [32] and dispersed human lung MC [33] through Gαs-coupled adenosine receptors. Similar to A1 and A3 receptors, P2Y receptors are Gαi-coupled purinergic receptors [34].

    • Cofactors in food allergy

      2017, Revue Francaise d'Allergologie
    • Bronchoprovocation Testing in Asthma

      2012, Immunology and Allergy Clinics of North America
    View all citing articles on Scopus
    View full text